EUVIMEDEUVIMED entdecken
Crossref

Probiotic-Derived Extracellular Vesicles as Immunomodulatory Agents in Autoimmune Disease Management

Milad Sadeghzadeh, Shabnam Farhadi, Helia Rahmati, Zahra Darabi, Fatemeh-zahra Ehsani, Masoomeh Basirat, Masoomeh Amini

Nanomedicine Research Journal · 2025-12 · 10 (4) · 375-389

DOI: 10.22034/nmrj.2025.04.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanomedicine Research Journal, 2025-12. Verfasst von Milad Sadeghzadeh und 6 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Probiotics have been extensively studied for their ability to restore microbial balance, strengthen the intestinal barrier, and regulate immune responses in humans. Among their bioactive components, probiotic-derived extracellular vesicles (PEVs) have emerged as key mediators of host–microbe interactions. PEVs are lipid-bilayer-enclosed postbiotic secreted by both Gram-negative and Gram-positive probiotic species, carrying diverse molecular cargo including proteins, lipids, nucleic acids, and metabolites. These vesicles enable targeted communication between probiotics and host cells, allowing them to exert biological effects independent of the viability of the parent bacteria. However, the biological activity and therapeutic potential of PEVs are influenced by multiple factors, such as the bacterial species of origin, culture conditions, and the methods used for their isolation and purification. Growing evidence indicates that PEVs play pivotal roles in modulating inflammation, enhancing gut barrier integrity, regulating metabolic pathways, and shaping host immune responses. This review summarizes an overview of current knowledge regarding the characteristics, functional mechanisms, and biomedical applications of PEVs, with a particular emphasis on their emerging role in the management of autoimmune-mediated disorders.

Schlagwörter

probiotic-derived extracellular vesiclesextracellular vesiclesimmunomodulation autoimmune diseasespostbioticgut– immune axis

Zitieren

APA

Sadeghzadeh, M., Farhadi, S., Rahmati, H., Darabi, Z., Ehsani, F., Basirat, M., & Amini, M. (2025). Probiotic-Derived Extracellular Vesicles as Immunomodulatory Agents in Autoimmune Disease Management. Nanomedicine Research Journal, 10(4), 375-389. https://doi.org/10.22034/nmrj.2025.04.006

Vancouver

Sadeghzadeh M, Farhadi S, Rahmati H, Darabi Z, Ehsani F, Basirat M, et al. Probiotic-Derived Extracellular Vesicles as Immunomodulatory Agents in Autoimmune Disease Management. Nanomedicine Research Journal. 2025;10(4):375-389. doi:10.22034/nmrj.2025.04.006

BibTeX
@article{Sadeghzadeh2025,
  author = {Sadeghzadeh, Milad and Farhadi, Shabnam and Rahmati, Helia and Darabi, Zahra and Ehsani, Fatemeh-zahra and Basirat, Masoomeh and Amini, Masoomeh},
  title = {Probiotic-Derived Extracellular Vesicles as Immunomodulatory Agents in Autoimmune Disease Management},
  journal = {Nanomedicine Research Journal},
  year = {2025},
  volume = {10},
  number = {4},
  pages = {375--389},
  doi = {10.22034/nmrj.2025.04.006}
}
Kostenlos starten →